Thursday, December 15, 2022 10:33:33 AM
https://www.otcmarkets.com/stock/DPLS/news/story?e&id=2406006
HOUSTON--(BUSINESS WIRE)-- DarkPulse, Inc. (OTC: DPLS) (“DarkPulse” or the “Company”), an emerging company which utilizes advanced technologies, including their patented dark-pulse BOTDA laser-based critical infrastructure monitoring systems, to create the foundational technology for the operation of Smart Cities, is pleased to announce the signing of a definitive business combination agreement with Global System Dynamics, Inc. (NASDAQ: GSD) (“GSD”), and GSD’s wholly owned merger subsidiary, Zilla Acquisition Corp. The combined company will be called “Global System Dynamics, Inc.” upon the closing of the transaction and is expected to be listed on NASDAQ under a new ticker symbol “DARK.”
Highlights of the transaction include:
Once the transaction is complete, DarkPulse will be delisted from the OTC Markets and will trade on the NASDAQ exchange. The transaction is expected to close in the first or second quarter of 2023.
The combined company will have an initial equity value of approximately $223 million which equates to an enterprise value of approximately $145 million, assuming no redemptions by GSD stockholders.
GSD currently has approximately $108.8 million cash in trust as of December 14, 2022.
The transaction is expected to provide DarkPulse with greater access to capital, better liquidity, and a wider investor audience as it pursues additional strategic and accretive acquisitions in the critical infrastructure industries of roadways, shipping, agriculture, and other industries that require structural monitoring.
The current Board of Directors of GSD will remain with three additional directors, Dennis O’Leary, Joseph Catalino, and George Pappas, respectively, to be appointed to join the Board of Directors at the closing of the transaction.
All existing DarkPulse shareholders will receive 100% of their equity in the pro forma company...
Recent DPLS News
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/09/2024 03:56:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2024 09:25:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/03/2024 07:14:41 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 12/18/2023 09:39:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/13/2023 08:18:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 05:00:09 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/15/2023 10:16:05 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2023 05:55:23 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/14/2023 05:15:11 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 11/07/2023 09:29:36 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 10/20/2023 09:17:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2023 12:04:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/03/2023 07:51:11 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 09/22/2023 08:41:26 PM
- Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 08/31/2023 09:19:17 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 08:32:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 05:01:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/03/2023 08:10:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2023 06:32:59 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/18/2023 09:16:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/10/2023 08:05:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/06/2023 06:21:32 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM